Search results
Medicare drug price negotiations unlikely to be derailed by lawsuits: UBS
Yahoo Finance via AOL· 9 months agoLawsuits brought by big pharmaceutical companies and industry lobbying groups are unlikely to delay...
Medicare's priciest drugs may get cheaper as feds start negotiations. Big Pharma objects.
USA TODAY via Yahoo News· 9 months agoThe Biden administration this week is expected to announce the first 10 prescription drugs the...
Medicare can now negotiate prices on these drugs to help seniors save
Newsy via AOL· 9 months agoThe exterior of Pfizer in Groton, Conn. The Biden administration announced the first 10 drugs...
U.S. drug price negotiations are underway. Here’s what that will mean for you—eventually
Fortune via AOL· 4 months agoNegotiations are underway between the federal government and pharmaceutical companies to determine...
What Impact Will Medicare Price Negotiations Have on Big Pharma Stocks?
Motley Fool· 9 months agoWhen Joe Biden ran for president in 2020, he promised to allow Medicare to negotiate directly with...
Could This Issue Sink Johnson & Johnson's Stock Price?
Motley Fool· 9 months agoPharmaceutical giant Johnson & Johnson (NYSE: JNJ) is no stranger to legal issues. This dark cloud...
Judge tosses Medicare drug negotiation challenges from Bristol Myers Squibb, Johnson & Johnson
The Hill via Yahoo Finance· 1 month agoA federal judge on Monday threw out legal challenges to the Medicare negotiation program that had...
5 things to know about the first 10 drugs chosen for Medicare negotiation
The Hill via Yahoo News· 9 months agoThe Biden administration has announced the first 10 drugs chosen for Medicare price negotiation,...
Medicare to negotiate prices with manufacturers of 10 major prescription drugs
United Press International via Yahoo News· 4 months agoDrug price negotiations, mandated by President Joe Biden's 2022 Inflation Reduction Act, seeks to...
Pharma CEOs grilled by senators over sky-high drug prices
NBC News via Yahoo News· 4 months agoWASHINGTON — Lawmakers sharply criticized the CEOs of three major drugmakers during a Senate...